SCHEMBL2905376

SCHEMBL2905376

CCCC(C(=O)O)P(=O)(O)O

nearest known ligand 0.61

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
FOLH1 Q04609 1/20 0.61
FDPS P14324 6/20 0.52
CHRM1 P11229 1/20 0.48
AKR1A1 P14550 1/20 0.48
CHRM3 P20309 1/20 0.48
HTR2A P28223 1/20 0.48
HTR2C P28335 1/20 0.48
ADRA1A P35348 1/20 0.48
HRH1 P35367 1/20 0.48
DRD3 P35462 1/20 0.48
SLC6A3 Q01959 1/20 0.48
HDAC1 Q13547 1/20 0.48
HDAC2 Q92769 1/20 0.48
TDP1 Q9NUW8 1/20 0.48
METAP1 P53582 2/20 0.45
POLB P06746 1/20 0.40
LAP3 P28838 1/20 0.39
GRIN2D O15399 1/20 0.38
GRIN3B O60391 1/20 0.38
GRIN1 Q05586 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3232568 0.86 FOLH1 (0.57) FOLH1FDPSLAP3
SCHEMBL2978558 0.86 CHRM1 (0.48) FOLH1FDPSCHRM1AKR1A1CHRM3
SCHEMBL389804 0.85 FDPS (0.57) FOLH1FDPSLAP3
SCHEMBL3470937 0.83 FDPS (0.59) FOLH1FDPSLAP3
SCHEMBL9841018 0.83 FDPS (0.59) FOLH1FDPSLAP3
SCHEMBL9487038 0.83 FDPS (0.59) FOLH1FDPSLAP3
SCHEMBL2023917 0.83 FDPS (0.59) FOLH1FDPSLAP3
SCHEMBL3377184 0.83 FDPS (0.59) FOLH1FDPSLAP3
SCHEMBL30595172 0.83 FDPS (0.59) FOLH1FDPSLAP3
SCHEMBL5575815 0.83 FDPS (0.59) FOLH1FDPSLAP3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 98 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12441950-B2 Lubricant compositions and methods for using the same ECOLAB USA INC. (US) 2025-10-14 US claimed
EP-4066644-A1 DISINFECTING CLEANER, METHOD FOR ITS PREPARATION AND ITS USE Carela GmbH (DE) 2022-10-05 EP claimed
EP-2807244-B1 LOW TEMPERATURE SULFOPEROXYCARBOXYLIC ACID CONTAINING CLEANING COMPOSITION ECOLAB USA INC (US) 2022-01-26 EP claimed
EP-2081600-A1 COMBINATION OF NMDA- RECEPTOR LIGAND AND A COMPOUND WITH 5-HT6 RECEPTOR AFFINITY Laboratorios Del. Dr. Esteve, S.A. (ES) 2009-07-29 EP claimed
WO-2008034815-A1 COMBINATION OF NMDA- RECEPTOR LIGAND AND A COMPOUND WITH 5-HT6 RECEPTOR AFFINITY LABORATORIOS DEL DR. ESTEVE, S.A. (ES) 2008-03-27 WO claimed
EP-0971712-A1 COMPOSITIONS FOR THE INHIBITION OF BONE RESORPTION Smith & Nephew plc (GB) 2000-01-19 EP claimed
WO-1998035674-A1 COMPOSITIONS FOR THE INHIBITION OF BONE RESORPTION SMITH & NEPHEW PLC (GB) 1998-08-20 WO claimed
EP-4741480-A2 NON-PHOSPHOROUS TRANSITION METAL CONTROL IN LAUNDRY APPLICATIONS Ecolab USA Inc. (US) 2026-05-13 EP disclosed
EP-3645694-B1 NON-PHOSPHOROUS TRANSITION METAL CONTROL IN LAUNDRY APPLICATIONS ECOLAB USA INC (US) 2026-04-15 EP disclosed
EP-3060640-B2 METHODS FOR REMOVING SOILS FROM SURFACES ECOLAB USA INC (US) 2026-02-18 EP disclosed
US-12534690-B2 Cleaning compositions and methods of use ECOLAB USA INC. (US) 2026-01-27 US disclosed
US-12441950-B2 Lubricant compositions and methods for using the same ECOLAB USA INC. (US) 2025-10-14 US disclosed
US-20250223522-A1 COMPOSITIONS AND METHODS FOR REMOVING SOIL FROM SURFACES ECOLAB USA INC. 2025-07-10 US disclosed
WO-1998035674-A1 COMPOSITIONS FOR THE INHIBITION OF BONE RESORPTION SMITH & NEPHEW PLC (GB) 1998-08-20 WO disclosed
US-5716967-A SELECTIVE INHIBITOR OF PHOSPHODIESTERASE TYPE 4, USEFUL IN TREATMENT OF ASTHMA, ARTHRITIS, BRONCHITIS, CHRONIC OBSTRUCTIVE PULMONARY DISEASE, PSORIASIS, ALLERGIC RHINITIS, DERMATITIS OR SHOCK PFIZER INC. (US) 1998-02-10 US disclosed
EP-0749428-A1 ISOXAZOLINE COMPOUNDS AS INHIBITORS OF TNF RELEASE PFIZER INC. (US) 1996-12-27 EP disclosed
EP-0730588-A1 ISOXAZOLINE COMPOUNDS AS ANTIINFLAMMATORY AGENTS PFIZER (US) 1996-09-11 EP disclosed
WO-1995024398-A1 ISOXAZOLINE COMPOUNDS AS INHIBITORS OF TNF RELEASE PFIZER INC. (US) 1995-09-14 WO disclosed
WO-1995014681-A1 ISOXAZOLINE COMPOUNDS AS ANTIINFLAMMATORY AGENTS PFIZER INC. (US) 1995-06-01 WO disclosed
EP-0290169-A2 Diamineplatinum complexes with phosphonocarboxylate and substituted phosphonocarboxylate ligands as antitumor agents ENGELHARD CORPORATION (US) 1988-11-09 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12534690-B2 Cleaning compositions and methods of use ARG1, ARGLU1, H1-0 FOLH1 894/4885FDPS 4561/4885CHRM1 51/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.